GENEWIZ Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • GENEWIZ's estimated annual revenue is currently $19.8M per year.(i)
  • GENEWIZ received $Undisclosed in venture funding in January 2016.
  • GENEWIZ's estimated revenue per employee is $155,000

Employee Data

  • GENEWIZ has 128 Employees.(i)
  • GENEWIZ grew their employee count by 0% last year.

GENEWIZ's People

NameTitleEmail/Phone
1
Director, Sales and Business Development, EuropeReveal Email/Phone
2
Associate Manager, Project ManagementReveal Email/Phone
3
Assistant Manager, NGSReveal Email/Phone
4
Assistant ManagerReveal Email/Phone
5
Senior Associate Study ManagerReveal Email/Phone
6
Sr. Research ScientistReveal Email/Phone
7
Principal ScientistReveal Email/Phone
8
Associate Scientist IIIReveal Email/Phone
9
Associate Laboratory Scientist IIReveal Email/Phone
10
Research And Development ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$69.6M449-1%N/AN/A
#2
$9.9M23356%$4.5M$221M
Add Company

What Is GENEWIZ?

GENEWIZ is a leading global genomics service company. A full-service provider, GENEWIZ provides DNA sequencing, gene synthesis, molecular biology, next generation sequencing, bioinformatics, and GLP regulatory and clinical services. From the company's founding, GENEWIZ has maintained its unwavering commitment to providing customers with the best value. Excelling in both science and customer support, GENEWIZ is dedicated to accelerating scientific discovery, as well as to developing and delivering innovative solutions for translational medicine and healthcare. Easily accessible around the world, GENEWIZ is the preferred partner at leading academic, pharmaceutical, biotechnology, agricultural, government, and clinical institutions. At GENEWIZ, it is our mission to contribute to the advancement of life sciences and technologies. Together with our clients, we can make a difference in the pursuit of scientific discoveries, better healthcare, a greener environment, and abundant food supplies. Our goal is to be the best in the world and the best for the world. Headquartered in South Plainfield, NJ, GENEWIZ is a privately-held global enterprise with locations in Boston, MA; Washington, DC Metro; Research Triangle Park, NC; San Diego, CA; San Francisco, CA; and Seattle, WA. International locations include Beijing, China; Suzhou, China; London, United Kingdom; Langen, Germany; and Tokyo, Japan. Follow us on Twitter, Instagram, and Facebook! (@GENEWIZ)

keywords:Biotechnology,Healthcare,Pharmaceuticals

N/A

Total Funding

128

Number of Employees

$19.8M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

GENEWIZ News

2022-04-19 - Genome Sequencing Service Market May See a Big Move ...

... QIAGEN, GENEWIZ, Macrogen, GE Healthcare Life Sciences, Johnson & Johnson, Abbott Laboratories, Bayer, Microchip Biotechnologies,...

2022-04-19 - Bioinformatics Services Market Size, Scope And Outlook ...

Illumina, BGI, Thermo Fisher Scientific, PerkinElmer, Eurofins Scientific, NeoGenomics, CD Genomics, Macrogen, QIAGEN, GENEWIZ,...

2022-04-17 - Global Metagenomic Sequencing Market 2022- Share, Size ...

Companies like BGI Group, DNAstar, Inc., Eurofins Scientific, GENEWIZ – Ripon College Days...

2021-04-07 - Brooks Life Sciences and GENEWIZ to Host 2-day Virtual Event Focused on Cell and Gene Therapy, April 7-8, 2021

Brooks Life Sciences and GENEWIZ to host 2-day virtual event focused on cell and gene therapy April 7-8, 2021 SOUTH PLAINFIELD, N.J. (PRWEB) April 07, 2021 The Advancing CGT Virtual Event presented by GENEWIZ and Brooks Life Sciences, opens on April 7-8, 2021 and aims to discuss the opportunit ...

2016-01-12 - GENEWIZ receives investment from OrbiMed for growth in its DNA sequencing, gene synthesis

A GENEWIZ representative was not available to comment on how much was raised or how the round of financing will be used. OrbiMed recently announced the closing of a major fund, bringing in $950 million with the help of investments from medical research institutions around the world, in addition ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$37.7M1305%N/A
#2
$26.7M13310%N/A
#3
$23.3M14628%N/A
#4
$28.9M1467%N/A
#5
$51.4M1615%N/A

GENEWIZ Funding

DateAmountRoundLead InvestorsReference
2016-01-12$UndisclosedUndisclosedOrbiMedArticle